Dr. Saro Sarkisian, MD

Dr. Sarkisian practices at Frederick Health Hospital in Frederick, Maryland, part of Frederick Health.

Dr. Sarkisian's NPI, 1164735387, was assigned on July 16, 2010. Dr. Sarkisian holds Maryland license D0090258.

Dr. Sarkisian's primary practice is Frederick Health Hospital, at 400 West Seventh St, Frederick, MD 21701 in Frederick County. The practice phone is (240) 566-3300.

Dr. Sarkisian's primary practice is Frederick Health Hospital in Frederick, Maryland, part of Frederick Health. Dr. Sarkisian is also affiliated with University of Maryland Medical Center. The medical group on file is Frederick Health Medical Group. Dmand AI also links Dr. Sarkisian to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarkisian practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sarkisian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sarkisian's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 91,623 Medicare services from Dr. Sarkisian across 50 procedure codes in 2024, for 958 Medicare patients. Medicare paid $1,072,190 for them.

CMS counts 958 Medicare patients who saw Dr. Sarkisian in 2024. The largest group is 65 to 74, with 404 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarkisian's median patient age at 66, with 46% women.

In 2024, Dr. Sarkisian wrote 1,067 Medicare Part D claims for 198 patients. 53% of them were for generic drugs. CMS names the drug for 916 of them, across 31 drugs with 11 or more claims each, at $4,214,258 in total drug cost. In 2023, CMS named 473 claims across 18 drugs.

Dr. Sarkisian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarkisian as offering telehealth.

Dmand AI links 7 papers to Dr. Sarkisian, published from 2013 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Melanoma, Molecular Targeted Therapy and Skin Neoplasms. Dr. Sarkisian has published most often in Cureus. Dr. Sarkisian's most frequent co-authors are Zeeshan M. Ali, MD, Suresh Nair, MD and Muhammad Rizvi, MD.

CMS Open Payments shows 91 general payments to Dr. Sarkisian from 27 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Astellas Pharma US Inc paid the most, $31,868.